TRAZODONE HCL

Trazodone HCl is a serotonin antagonist and reuptake inhibitor used for depression and insomnia. Side effects include sedation, dizziness, priapism, orthostatic hypotension, and GI disturbances. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 4f9c7096f3b3 Category: Tag:

Product Description


Mechanism of Action

TRAZODONE HCL demonstrates a multilayer biochemical interaction architecture integrating highbandwidth signalling interference, catalyticdomain perturbation, mitochondrialnetwork recalibration, ionflux redistribution, cytoskeletal restructuring, membranepotential modulation and transcriptionfactor pathway realignment. Its molecular conformation enables docking to catalytic residues, allosteric nodes, transmembrane helices, nucleotidebinding pockets, redoxbuffer centres and polymeric scaffolding complexes, providing systemwide influence across metabolic, electrophysiological, structural and genomic domains.

At the signalling stratum, TRAZODONE HCL may reshape phosphorylation landscapes, alter the propagation kinetics of ERK, MAPK, JNK and p38 pathways, modulate PI3KAKT survival gating, adjust Gprotein coupling efficiency, redistribute Ca²⁺ microdomains, influence IP/DAG signalling geometry, and redefine cAMPPKA amplitude. Mitochondrial effects include ETCcomplex rebalancing, ATP/ADP cycle remapping, ROSthreshold displacement, membranepotential polarity modulation and crossorganelle stress signalling.

HighPrecision

  • Kinomescale cascade interference mapping & catalyticpathway reconstruction
  • Highresolution docking, ligandmetastability tracking & conformationalflow modelling
  • UPR/ERstress, mitophagy and organelle crosstalk quantification
  • Multiomics regulatorynetwork reconstruction (RNAseq, metabolomics, phosphoproteomics, proteomics)
  • Cytoskeletal mechanics including actin/tubulin turnover and forcedistribution modelling
  • Cellfate simulations across apoptosis, necroptosis, ferroptosis & parthanatos pathways
  • AIenhanced SAR/QSAR optimisation engines for predictive compound modelling

Toxicodynamics & Cellular Hazard Spectrum

  • Acute ROS surge and antioxidantbuffer saturation
  • Mitochondrial fragmentation or ETCaxis collapse
  • Severe Na⁺/K⁺/Ca²⁺ ionhomeostasis destabilisation
  • Cytoskeletal depolymerisation & structuralintegrity failure
  • Membranetension breakdown & lipidbilayer thinning
  • Hyperactivation of inflammatory master regulators (NF-κB, STAT, IRF families)
  • Activation of multiple programmed-cell-death pathways
  • Epigenetic drift including methylation and acetylation instability

For expert not intended for biological or therapeutic exposure.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C19H22ClN5O·HCl

Molecular Weight

408.3 g/mol

CAS Number

25332-39-2

Storage Condition

Store at 20 deg to 25 °C (68 deg to 77 °F).

Solubility

2.90e-01 g/L

Purity

Purity information is available upon request (COA).

Synonym

Trazodone hydrochloride; 25332-39-2; Trazodone Hcl; Trialodine; Oleptro

IUPAC/Chemical Name

2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride

InChl Key

OHHDIOKRWWOXMT-UHFFFAOYSA-N

InChl Code

InChI=1S/C19H22ClN5O.ClH/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25;/h1-3,5-7,9,15H,4,8,10-14H2;1H

References

https://pubchem.ncbi.nlm.nih.gov/compound/62935;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download